Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence

Immunity

Volumn 19, Issue 4, 2003, Pages 583-593

  Martin, Coralie ^a   Burdon, Peter C E ^a   Bridger, Gary ^b   Gutierrez Ramos, Jose Carlos ^c   Williams, Timothy J ^a   Rankin, Sara M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GENZYME CORPORATION   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR2 AGONIST; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; IMMUNOLOGIC AGENT; RECEPTOR BLOCKING AGENT; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL AGING; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LEUKOCYTE MIGRATION INHIBITION; LEUKOCYTE MOTILITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SENESCENCE;

EID: 0142188265     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00263-2     Document Type: Article

References (33)

1. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1996;1101-1109.
2. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1997;1925-1930.
3. Bruhl H., Wagner K., Kellner H., Schattenkirchner M., Schlondorff D., Mack M. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin. Exp. Immunol. 126:2001;551-559.
4. Forster R., Kremmer E., Schubel A., Breitfeld D., Kleinschmidt A., Nerl C., Bernhardt G., Lipp M. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocytesubsets. rapid internalization and recycling upon activation J. Immunol. 160:1998;1522-1531.
5. Gonzalo J.A., Lloyd C.M., Peled A., Delaney T., Coyle A.J., Gutierrez-Ramos J.C. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J. Immunol. 165:2000;499-508.
6. Haribabu B., Richardson R.M., Verghese M.W., Barr A.J., Zhelev D.V., Snyderman R. Function and regulation of chemoattractant receptors. Immunol. Res. 22:2000;271-279.
7. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med. 160:1999;S5-11.
8. Haslett C., Guthrie L.A., Kopaniak M.M., Johnston R.B. Jr., Henson P.M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 119:1985;101-110.
9. Hatse S., Princen K., Bridger G., De Clercq E., Schols D. Chemokine receptor inhibition by AMD-3100 is strictly confined to CXCR4. FEBS Lett. 527:2002;255-262.
10. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., Hackett N.R., Quitoriano M.S., Crystal R.G., Rafii S.et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 97:2001;3354-3360.
11. Hendrix C.W., Flexner C., MacFarland R.T., Giandomenico C., Fuchs E.J., Redpath E., Bridger G., Henson G.W. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 44:2000;1667-1673.
12. Hernandez P.A., Gorlin R.J., Lukens J.N., Taniuchi S., Bohinjec J., Francois F., Klotman M.E., Diaz G.A. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34:2003;70-74.
13. Honczarenko M., Le Y., Glodek A.M., Majka M., Campbell J.J., Ratajczak M.Z., Silberstein L.E. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood. 100:2002;2321-2329.
14. Hori T., Sakaida H., Sato A., Nakajima T., Shida H., Yoshie O., Uchiyama T. Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies. J. Immunol. 160:1998;180-188.
15. Jagels M.A., Hugli T.E. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. J. Immunol. 148:1992;1119-1128.
16. Kowalska M.A., Ratajczak J., Hoxie J., Brass L.F., Gewirtz A., Poncz M., Ratajczak M.Z. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface. determination of response to stromal-derived factor-1 by megakaryocytes and platelets Br. J. Haematol. 104:1999;220-229.
17. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111:2003;187-196.
18. Loetscher P., Gong J.H., Dewald B., Baggiolini M., Clark-Lewis I. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J. Biol. Chem. 273:1998;22279-22283.
19. Lovas K., Knudsen E., Iversen P.O., Benestad H.B. Sequestration patterns of transfused rat neutrophilic granulocytes under normal and inflammatory conditions. Eur. J. Haematol. 56:1996;221-229.
20. Ma Q., Jones D., Springer T.A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 10:1999;463-471.
21. Mohle R., Bautz F., Rafii S., Moore M.A., Brugger W., Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 91:1998;4523-4530.
22. Nagase H., Miyamasu M., Yamaguchi M., Imanishi M., Tsuno N.H., Matsushima K., Yamamoto K., Morita Y., Hirai K. Cytokine-mediated regulation of CXCR4 expression in human neutrophils. J. Leukoc. Biol. 71:2002;711-717.
23. Palframan R.T., Collins P.D., Severs N.J., Rothery S., Williams T.J., Rankin S.M. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5. the role of specific adhesion molecules and phosphatidylinositol 3-kinase J. Exp. Med. 188:1998;1621-1632.
24. Patel L., Charlton S.J., Chambers J.K., Macphee C.H. Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations. Cytokine. 14:2001;27-36.
25. Richardson R.M., Tokunaga K., Marjoram R., Sata T., Snyderman R. Interleukin-8-mediated heterologous receptor internalization provides resistance to HIV-1 infectivity. Role of signal strength and receptor desensitization. J. Biol. Chem. 278:2003;15867-15873.
26. Sabroe I., Hartnell A., Jopling L.A., Bel S., Ponath P.D., Pease J.E., Collins P.D., Williams T.J. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J. Immunol. 162:1999;2946-2955.
27. Saverymuttu S.H., Peters A.M., Keshavarzian A., Reavy H.J., Lavender J.P. The kinetics of 111indium distribution following injection of 111indium labelled autologous granulocytes in man. Br. J. Haematol. 61:1985;675-685.
28. Semerad C.L., Liu F., Gregory A.D., Stumpf K., Link D.C. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 17:2002;413-423.
29. Suratt B.T., Young S.K., Lieber J., Nick J.A., Henson P.M., Worthen G.S. Neutrophil maturation and activation determine anatomic site of clearance from circulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L913-L921.
30. Tarasova N.I., Stauber R.H., Michejda C.J. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J. Biol. Chem. 273:1998;15883-15886.
31. Terashima T., English D., Hogg J.C., van Eeden S.F. Release of polymorphonuclear leukocytes from the bone marrow by interleukin-8. Blood. 92:1998;1062-1069.
32. Thakur M.L., Lavender J.P., Arnot R.N., Silvester D.J., Segal A.W. Indium-111-labeled autologous leukocytes in man.J. Nucleic Med. 10:1977;1014-1021.
33. White J.R., Lee J.M., Young P.R., Hertzberg R.P., Jurewicz A.J., Chaikin M.A., Widdowson K., Foley J.J., Martin L.D., Griswold D.E.et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J. Biol. Chem. 273:1998;10095-10098.